Kezar Historical Financial Ratios
| KZR Stock | USD 7.47 0.07 0.95% |
Kezar Life is lately reporting on over 93 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Days Sales Outstanding of 0.0 will help investors to properly organize and evaluate Kezar Life Sciences financial condition quickly.
Kezar |
About Kezar Financial Ratios Analysis
Kezar Life SciencesFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Kezar Life investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Kezar financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Kezar Life history.
Kezar Life Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Kezar Life Sciences stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Kezar Life sales, a figure that is much harder to manipulate than other Kezar Life Sciences multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Invested Capital
Invested capital represents the total cash investment that shareholders and debt holders have contributed to Kezar Life Sciences. There are two different methods for calculating Kezar Life Sciences invested capital: operating approach and financing approach. Understanding Kezar Life invested capital allows investors to calculate measures of performance such as return on invested capital or return on capital employed.Average Payables
The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.Ev To Sales
The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.Most ratios from Kezar Life's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Kezar Life Sciences current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kezar Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. At this time, Kezar Life's Interest Debt Per Share is relatively stable compared to the past year. As of 12/02/2024, Price Book Value Ratio is likely to grow to 3.85, though Free Cash Flow Yield is likely to grow to (0.12).
| 2021 | 2023 | 2024 (projected) | Payables Turnover | 0.74 | 0.13 | 0.12 | Days Of Inventory On Hand | 604.3 | 543.87 | 377.62 |
Kezar Life fundamentals Correlations
Click cells to compare fundamentals
Kezar Life Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Kezar Life fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Ptb Ratio | 9.81 | 16.29 | 44.81 | 17.57 | 3.66 | 3.85 | |
| Book Value Per Share | 4.09 | 3.2 | 3.73 | 4.01 | 2.59 | 2.49 | |
| Free Cash Flow Yield | (0.009045) | (0.0398) | (0.0162) | (0.004847) | (0.0127) | (0.12) | |
| Operating Cash Flow Per Share | (1.57) | (0.84) | (0.8) | (0.87) | (1.13) | (1.18) | |
| Capex To Depreciation | 0.47 | 0.13 | 0.21 | 1.54 | 1.7 | 1.2 | |
| Pb Ratio | 9.81 | 16.29 | 44.81 | 17.57 | 3.66 | 3.85 | |
| Free Cash Flow Per Share | (1.6) | (0.84) | (0.81) | (0.9) | (1.15) | (1.21) | |
| Roic | (0.24) | (0.4) | (0.27) | (0.26) | (0.52) | (0.5) | |
| Net Income Per Share | (1.65) | (0.89) | (1.01) | (0.97) | (1.4) | (1.47) | |
| Payables Turnover | 1.58 | 0.65 | 0.74 | 0.41 | 0.13 | 0.12 | |
| Cash Per Share | 4.1 | 3.19 | 3.95 | 4.11 | 2.78 | 4.58 | |
| Pocfratio | (25.61) | (62.17) | (207.87) | (80.6) | (8.42) | (8.84) | |
| Capex To Operating Cash Flow | (0.0203) | (0.00525) | (0.007446) | (0.0268) | (0.0222) | (0.0233) | |
| Pfcf Ratio | (25.1) | (61.84) | (206.33) | (78.49) | (8.23) | (8.64) | |
| Days Payables Outstanding | 230.9 | 557.43 | 490.21 | 884.49 | 2.8K | 3.0K | |
| Income Quality | 0.85 | 0.89 | 0.78 | 0.86 | 0.8 | 0.98 | |
| Roe | (0.4) | (0.28) | (0.27) | (0.24) | (0.54) | (0.52) | |
| Ev To Operating Cash Flow | (25.33) | (61.74) | (206.72) | (80.27) | (8.21) | (8.62) | |
| Pe Ratio | (24.27) | (58.91) | (165.57) | (72.61) | (6.74) | (7.08) | |
| Return On Tangible Assets | (0.35) | (0.26) | (0.24) | (0.22) | (0.46) | (0.48) | |
| Ev To Free Cash Flow | (24.82) | (61.42) | (205.19) | (78.17) | (8.03) | (8.44) | |
| Earnings Yield | (0.0412) | (0.017) | (0.00604) | (0.0138) | (0.15) | (0.14) | |
| Net Debt To E B I T D A | 0.25 | 0.39 | 0.92 | 0.29 | 0.17 | 0.16 | |
| Current Ratio | 13.52 | 22.48 | 25.77 | 25.98 | 11.66 | 11.08 | |
| Tangible Book Value Per Share | 4.09 | 3.2 | 3.73 | 4.01 | 2.59 | 2.49 | |
| Graham Number | 12.33 | 7.99 | 9.21 | 9.35 | 9.04 | 8.1 | |
| Shareholders Equity Per Share | 4.09 | 3.2 | 3.73 | 4.01 | 2.59 | 2.49 | |
| Capex Per Share | 0.0318 | 0.004409 | 0.005989 | 0.0234 | 0.0249 | 0.033 | |
| Graham Net Net | 3.53 | 2.97 | 3.57 | 3.66 | 2.31 | 2.22 | |
| Enterprise Value Over E B I T D A | (21.98) | (56.67) | (165.64) | (71.45) | (6.76) | (7.09) | |
| Price Earnings Ratio | (24.27) | (58.91) | (165.57) | (72.61) | (6.74) | (7.08) | |
| Price Book Value Ratio | 9.81 | 16.29 | 44.81 | 17.57 | 3.66 | 3.85 | |
| Price Earnings To Growth Ratio | 0.9 | 1.28 | (12.28) | 18.33 | (0.15) | (0.14) | |
| Days Of Payables Outstanding | 230.9 | 557.43 | 490.21 | 884.49 | 2.8K | 3.0K |
Pair Trading with Kezar Life
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Kezar Life position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kezar Life will appreciate offsetting losses from the drop in the long position's value.Moving against Kezar Stock
| 0.82 | VCNX | Vaccinex | PairCorr |
| 0.54 | VALN | Valneva SE ADR | PairCorr |
| 0.54 | DRMA | Dermata Therapeutics | PairCorr |
| 0.38 | ME | 23Andme Holding Upward Rally | PairCorr |
| 0.34 | DRRX | Durect | PairCorr |
The ability to find closely correlated positions to Kezar Life could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Kezar Life when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Kezar Life - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Kezar Life Sciences to buy it.
The correlation of Kezar Life is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Kezar Life moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Kezar Life Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Kezar Life can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Kezar Stock Analysis
When running Kezar Life's price analysis, check to measure Kezar Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kezar Life is operating at the current time. Most of Kezar Life's value examination focuses on studying past and present price action to predict the probability of Kezar Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kezar Life's price. Additionally, you may evaluate how the addition of Kezar Life to your portfolios can decrease your overall portfolio volatility.